32 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32829374 | Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells. | 2020 Aug 23 | 3 |
2 | 30829071 | Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway. | 2019 Dec | 6 |
3 | 30084832 | Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. | 2018 Oct 15 | 1 |
4 | 28117030 | Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells. | 2017 Sep 21 | 1 |
5 | 26799187 | p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells. | 2016 Feb 16 | 8 |
6 | 25858687 | Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3 inflammasome. | 2015 Aug | 2 |
7 | 26503059 | IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel. | 2015 Oct 27 | 1 |
8 | 24681252 | CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy. | 2014 Aug | 1 |
9 | 24787013 | Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases. | 2014 May 1 | 1 |
10 | 23228696 | Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel. | 2013 Feb 15 | 7 |
11 | 21074392 | Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemia K562 cells. | 2012 May | 1 |
12 | 21968419 | c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells. | 2012 Jan | 1 |
13 | 19918793 | Taxol induces paraptosis independent of both protein synthesis and MAPK pathway. | 2010 Feb | 1 |
14 | 20624405 | Additive effects of C(2)-ceramide on paclitaxel-induced premature senescence of human lung cancer cells. | 2010 Sep 11 | 1 |
15 | 19048624 | Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. | 2009 Mar 15 | 3 |
16 | 19717209 | Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells. | 2009 Dec | 1 |
17 | 17987264 | Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. | 2008 Mar | 1 |
18 | 18068334 | Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. | 2008 Feb | 4 |
19 | 18704310 | Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells. | 2008 Aug | 1 |
20 | 17974988 | Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. | 2007 Nov 1 | 1 |
21 | 18231754 | The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells. | 2007 Dec | 5 |
22 | 16515784 | ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. | 2006 May 15 | 3 |
23 | 15657900 | Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. | 2005 May 20 | 3 |
24 | 15700118 | Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells. | 2005 Feb | 1 |
25 | 12796407 | Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. | 2003 Jun | 3 |
26 | 12821934 | Role of the p38 MAPK pathway in cisplatin-based therapy. | 2003 Jun 26 | 2 |
27 | 12181443 | Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific. | 2002 Sep | 1 |
28 | 12516968 | Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase. | 2002 Dec | 1 |
29 | 11313944 | Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. | 2001 Jan 11 | 3 |
30 | 11408609 | Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. | 2001 Jul | 2 |
31 | 11597122 | Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases. | 2001 Oct 15 | 1 |
32 | 10623471 | Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. | 2000 Jan 10 | 1 |